From April 17 to 18, the 4th Synthetic Biology Industry Expo 2026 (SBC2026) grandly opened at the Nanjing Yangtze River International Conference Center. As a leader in industrialization services for synthetic biology, TIANS Group, with "Lab to Fab" as its core logic, showcased on-site general contracting services for synthetic biology industrialization projects, the "TIANS Model", and a number of cutting-edge engineering and technological achievements, and provided an in-depth analysis of how to bridge the "last mile" of large-scale production in biomanufacturing.

SBC2026 Nanjing Synthetic Biology Exhibition

Intelligent Manufacturing for the Future: Renowned Experts Focus on Synthetic Biology Engineering Practice

At the sub-forum on "Biomanufacturing and New Materials" held concurrently with the exhibition, Yang Liguo, a renowned expert in synthetic biological process design and Deputy Chief Engineer of the Design Center of TIANS Group, delivered a keynote speech entitled "Biological Intelligent Manufacturing, Empowering the Future: Industrial Engineering Design and Practice of Synthetic Biology". He stated that advanced engineering design serves as a crucial bridge connecting synthetic biology from research and development to large-scale production, and elaborated on aspects including aseptic design, economic design, intelligent design, systematic design, green design, and safety design in detail. Mr. Yang Liguo emphasized that preventing contamination is the top priority in fermentation workshops. Although contamination risks can be avoided through advanced sterilization processes, appropriate inoculation and feeding methods, dehumidification and sterilization of compressed air, and rational workshop layout, there still remains a contamination challenge of approximately 30% with unknown causes. Engineering design must go beyond the "drawing" stage and achieve an in-depth integration of process mechanisms and on-site experience.

Keynote speech entitled "Biological Intelligent Manufacturing, Empowering the Future: Industrial Engineering Design and Practice of Synthetic Biology"

Precise Empowerment: The "TIANS Model" Leads the Path to Industrialization
In the field of synthetic biology, a core pain point plaguing the industry is how to scale up strains from laboratory research to ton-level production while maintaining high conversion rates and yields. As a leader in the industrialization of synthetic biology, TIANS prominently showcased at this exhibition its integrated "General Contracting for Synthetic Biology Industrialization Engineering" solution, which combines process technology development, engineering consulting and design, engineering procurement construction (EPC), automation and informatization, and intelligent equipment. It also presented the new engineering model empowering the industrialization of new synthetic biology technologies—the "TIANS Model". To date, this model has been successfully applied to leading enterprises in various synthetic biology sub-sectors such as amino acids, enzyme preparations, antibiotics, polyols, bio-based materials, and non-grain biomass, including Huaheng Biotech, Chuanning Biotech, Jinhai Biotech, VTR, Jinbo Biotechnology, Juwei Yuanchuang Biotechnology, and Everbright Lianfeng Biotechnology.

TIANS Group booth

As synthetic biology moves from "accumulating momentum" to "exponential growth", TIANS deeply understands that the core competitiveness of industrialization lies not only in the iteration of bacterial strains, but also in the deep integration of process technology, engineering design and engineering management thinking. TIANS will continue to uphold its brand positioning of "empowering the industrialization of new technologies", leverage its advantages in complex process packages, intelligent manufacturing and green concepts, and jointly explore the infinite possibilities of biomanufacturing.